Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women.
about
ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation.Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy.Aspirin Use in Women: Current Perspectives and Future Directions.Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women's Health Study.
P2860
Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@ast
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@en
type
label
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@ast
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@en
prefLabel
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@ast
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@en
P2093
P2860
P1476
Personalizing Aspirin Use for ...... ntion in Postmenopausal Women.
@en
P2093
Aditya Bardia
Alice H Wang
DeAnn Lazovich
James R Cerhan
Jon O Ebbert
Kristin E Anderson
Paul J Limburg
Robert A Vierkant
Tanya E Keenan
P2860
P356
10.1016/J.MAYOCP.2015.10.018
P407
P577
2015-12-08T00:00:00Z